Knott David M Jr — 13F Holdings & Portfolio

CIK 1892770 · latest 13F-HR filed 2026-11-12

Knott David M Jr manages $182.8M in 13F-reported U.S. long-equity assets across 82 reported positions as of its 2026-09-30 13F-HR filing. Its largest disclosed positions are GOOG (17.00%), APO (14.28%), IOVA (9.44%). Quarter over quarter (versus its 2026-06-30 filing) the fund opened 8 new positions and exited 12; 22 existing positions rose in reported value and 30 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$182.8M

Long-equity book

Holdings
82

Distinct positions

Period
2026-09-30

Filed 2026-11-12

Q/Q Activity
+8 / −12 / ↑22 / ↓30

vs 2026-06-30

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Portfolio map

Q3 26

Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.

Sector mix

% of 13F value

Sectors from each company's SIC code; funds and ETFs grouped separately.

Biggest buys and sells

Q2 26 → Q3 26

Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.

13F assets and positions

5 quarters

Total reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.

Top positions over time

reported value

The eight largest current positions, valued at each quarter end.

Concentration

top 10 = 66.7%

Cumulative share of the portfolio held in the largest N positions.

Firm Profile & Key People

Name Title / Status Ownership Type

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Knott David M Jr Holdings (2026-09-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 Alphabet Inc-Cl C GOOG 02079K107 $31.1M 17.00% 91,200 SH
2 Apollo Global Management, Inc. APO 03769M106 $26.1M 14.28% 225,000 SH
3 Iovance Biotherapeutics, Inc. IOVA 462260100 $17.3M 9.44% 1,165,000 SH
4 Xeris Biopharma Holdings, Inc. XERS 98422E103 $9.6M 5.24% 1,002,900 SH
5 Syndax Pharmaceutical, Inc. SNDX 87164F105 $8.1M 4.40% 428,294 SH
6 Travere Therapeutics, Inc. TVTX 89422G107 $7.7M 4.19% 129,967 SH
7 Bridgebio Pharma, Inc. BBIO 10806X102 $6.6M 3.60% 100,000 SH
8 JPMorgan Chase & Co. JPM 46625H100 $5.8M 3.15% 17,409 SH
9 LPL Financial Holdings Inc. LPLA 52012V100 $5.0M 2.76% 16,500 SH
10 Janus Henderson AAA CLO ETF JAAA 47103U845 $4.7M 2.58% 93,528 SH
11 Alkermes PLC ALKS G01767105 $4.6M 2.54% 114,459 SH
12 Protagonist Therapeutics, Inc PTGX 74366E102 $4.6M 2.52% 32,723 SH
13 Cybin Inc HELP 23256X407 $4.5M 2.49% 370,000 SH
14 Cogent Biosciences Inc. COGT 19240Q201 $4.4M 2.38% 136,081 SH
15 Viridian Therapeutics, Inc. VRDN 92790C104 $3.9M 2.15% 191,000 SH
16 TG Therapeutics, Inc. TGTX 88322Q108 $3.3M 1.83% 59,839 SH
17 Arcus Biosciences, Inc. RCUS 03969F109 $2.6M 1.42% 100,241 SH
18 Madrigal Pharmaaceuticals, Inc. MDGL 558868105 $1.8M 0.99% 3,600 SH
19 Relmada Therapeutics, Inc. RLMD 75955J402 $1.8M 0.99% 480,000 SH
20 SPDR S&P Biotech ETF XBI 78464A870 $1.7M 0.95% 11,000 SH
21 AllianceBernstein Holding L.P. AB 01881G106 $1.7M 0.92% 48,000 SH
22 Agios Pharmaceutical, Inc. AGIO 00847X104 $1.6M 0.89% 49,058 SH
23 Orchestra Biomed Holdings, Inc. OBIO 68572M106 $1.6M 0.86% 253,651 SH
24 Cullinan Therapeutics, Inc. CGEM 230031106 $1.5M 0.80% 95,369 SH
25 CareDx, Inc. CDNA 14167L103 $1.4M 0.79% 22,165 SH
26 Enliven Therapeutics, Inc. ELVN 29337E102 $1.3M 0.72% 28,904 SH
27 Spruce Biosciences, Inc. SPRB 85209E208 $1.3M 0.69% 26,085 SH
28 Eldgridge BBB-B CLOZ 81752T528 $1.3M 0.69% 47,807 SH
29 DocGo, Inc. DCGO 256086109 $1.1M 0.58% 2,670,850 SH
30 Pfizer Inc. PFE 717081103 $922.3K 0.50% 32,337 SH
31 Oruka Therapeutics, Inc. ORKA 687604108 $916.2K 0.50% 11,000 SH
32 Collegium Pharmaceutical, Inc. COLL 19459J104 $851.0K 0.47% 39,000 SH
33 Dyne Therapeutics, Inc. DYN 26818M108 $837.7K 0.46% 52,000 SH
34 Apple Inc. AAPL 037833100 $830.6K 0.45% 2,494 SH
35 Microsoft Corporation MSFT 594918104 $820.6K 0.45% 1,600 SH
36 Rezolute, Inc. RZLT 76200L309 $660.9K 0.36% 159,638 SH
37 Canadian Natural Resources Limited CNQ 136385101 $655.1K 0.36% 13,918 SH
38 LB Pharmaceuticals, Inc. LBRX 50180M108 $655.0K 0.36% 17,065 SH
39 Johnson & Johnson JNJ 478160104 $529.5K 0.29% 2,000 SH
40 iShares Biotechnology ETF IBB 464287556 $526.3K 0.29% 2,500 SH
41 Solid Bioscience Inc. SLDB 83422E204 $514.3K 0.28% 71,129 SH
42 DuPont de Nemours, Inc. DD 26614N102 $489.3K 0.27% 3,767 SH
43 International Business Machines IBM 459200101 $471.1K 0.26% 2,142 SH
44 Connect Biopharma Holdings Limited CNTB G23549101 $461.9K 0.25% 419,866 SH
45 Biogen Inc. BIIB 09062X103 $451.8K 0.25% 2,000 SH
46 Edgewise Therapeutics, Inc. EWTX 28036F105 $426.4K 0.23% 10,502 SH
47 Pelthos Therapeutics, Inc. PTHS 171126204 $370.7K 0.20% 17,644 SH
48 Nvidia Corp NVDA 67066G104 $292.3K 0.16% 1,280 SH
49 Ryman Hospitality Properties, Inc. RHP 78377T107 $286.9K 0.16% 2,400 SH
50 Insmed Incorporated INSM 457669307 $257.2K 0.14% 2,253 SH
Filing History
Period Filed AUM Holdings Accession
2026-09-30 2026-11-12 $182.8M 82 0001104659-26-125757
2026-06-30 2026-08-12 $189.2M 86 0001104659-26-094536
2026-03-31 2026-05-14 $168.0M 88 0001104659-26-060750
2025-12-31 2026-02-12 $215.9M 91 0001104659-26-014058
2025-09-30 2025-11-12 $248.0M 92 0001104659-25-110124
Filer Information
Address
DORSET PARTNERS LLC
485 UNDERHILL BOULEVARD, SUITE 205
SYOSSET, NY 11791
Phone
(516) 364-0303
Filing Manager
Knott David M Jr
SYOSSET, NY
Signatory
Knott David M Jr
Investment Manager